Hypogonadism in chronic obstructive pulmonary disease: incidence and effects

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current opinion in pulmonary medicine

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MCP.0b013e32834feb37PMID 22234275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current research: Chronic obstructive pulmonary disease: effects beyond the lungs

  2013cited by this paper
• Relationship Between Depressive Symptoms and Hypogonadism in Men with COPD

  2011cited by this paper
• Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis

  2011cited by this paper
• Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

  2010cited by this paper
• Androgens and chronic obstructive pulmonary disease

  2010cited by this paper
• Skeletal muscle dysfunction in chronic obstructive pulmonary disease

  2009cited by this paper
• Sex hormone alterations and systemic inflammation in chronic obstructive pulmonary disease

  2009cited by this paper
• Mechanism of androgen receptor action.

  2009cited by this paper
• Androgens and bone

  2008cited by this paper
• Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

  2008cited by this paper
• Obstructive Sleep Apnoea, Cigarette Smoking and Serum Testosterone Levels in a Male Sleep Clinic Cohort

  2007cited by this paper
• Male hypogonadism in systemic disease.

  2007cited by this paper
• Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone. The Tromsø Study

  2007cited by this paper
• Chronic obstructive pulmonary disease: effects beyond the lungs

  2006cited by this paper
• Testosterone therapy in glucocorticoid-treated men

  2006cited by this paper
• Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life.

  2005cited by this paper
• Respiratory and skeletal muscles in hypogonadal men with chronic obstructive pulmonary disease.

  2005cited by this paper
• Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

  2005cited by this paper
• Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease.

  2005cited by this paper
• Testosterone Treatment Improves Body Composition and Sexual Function in Men With COPD, in a 6-Month Randomized Controlled Trial.

  2005cited by this paper
• Risk factors for androgen decline in older males: lifestyle, chronic diseases and drugs.

  2005cited by this paper
• Gonadal dysfunction in systemic diseases.

  2005cited by this paper
• Androgens and bone.

  2004cited by this paper
• Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study.

  2004cited by this paper
• Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease.

  2004cited by this paper
• Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial.

  2004cited by this paper
• Catabolic/anabolic balance and muscle wasting in patients with COPD.

  2003cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I

  2003cited by this paper
• Endocrinological disturbances in chronic obstructive pulmonary disease

  2003cited by this paper
• The short-term effects of high-dose testosterone on sleep, breathing, and function in older men.

  2003cited by this paper
• Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.

  2003cited by this paper
• Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

  2002cited by this paper
• Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study.

  2002cited by this paper
• American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.

  2002cited by this paper
• American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.

  2002cited by this paper
• COPD and osteoporosis.

  2002cited by this paper
• Diagnosis of hypogonadism in the aging male

  2002cited by this paper
• Sex steroids and bone.

  2002cited by this paper
• Sex steroids and bone.

  2001cited by this paper
• Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

  2001cited by this paper
• Inflammatory response and body composition in chronic obstructive pulmonary disease.

  2001cited by this paper
• Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease.

  2000cited by this paper
• Effects of testosterone replacement in hypogonadal men.

  2000cited by this paper
• Venous thromboembolism.

  1999cited by this paper
• Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function.

  1999cited by this paper
• Skeletal muscle dysfunction in chronic obstructive pulmonary disease: A statement of the American Thoracic Society and European Respiratory Society

  1999cited by this paper
• Anabolic steroids.

  1999cited by this paper
• The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients.

  1998cited by this paper
• Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy.

  1998cited by this paper
• Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease.

  1998cited by this paper
• Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.

  1998cited by this paper
• Testosterone therapy in glucocorticoid-treated men.

  1996cited by this paper
• Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial.

  1995cited by this paper
• Androgens and bone

  1995cited by this paper
• Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.

  1995cited by this paper
• Effect of testosterone on muscle mass and muscle protein synthesis.

  1989cited by this paper
• Biological actions of androgens.

  1987cited by this paper
• Atrophy of Leydig cells in the testes of men with longstanding chronic bronchitis and emphysema.

  1987cited by this paper
• Reduction of serum testosterone levels during chronic glucocorticoid therapy.

  1986cited by this paper
• Sex hormone suppression and sexual impotence in hypoxic pulmonary fibrosis.

  1984cited by this paper
• Anabolic Steroids.

  1983cited by this paper
• Serum testosterone depression associated with hypoxia in respiratory failure.

  1980cited by this paper

• Relationship Between Anemia, and Serum Testosterone Levels in Chronic Obstructive Pulmonary Disease Patients: A Cross-sectional Study

  2025cites this paper
• Sex Steroids in COVID-19 Patients with Hypertension: An Exploratory Study

  2025cites this paper
• Association between hypogonadism and severity of chronic obstructive pulmonary disease: A cross-sectional study.

  2024cites this paper
• Prevalence of hypogonadism in men with and without chronic obstructive pulmonary disease: A cross-sectional study.

  2024cites this paper
• Testosterone replacement therapy in patients with cachexia: a contemporary review of the literature.

  2024cites this paper
• Association of serum testosterone with chronic obstructive pulmonary disease (COPD) in a nationally representative sample of White, Black, and Hispanic men

  2023cites this paper
• Low testosterone levels as an independent risk factor for mortality in male patients with COVID-19: Report of a Single-Center Cohort Study in Mexico

  2023cites this paper
• Association of testosterone therapy with disease progression in older males with COVID‐19

  2022cites this paper
• Testosterone Treatment As a Function-Promoting Therapy in Sarcopenia Associated with Aging and Chronic Disease.

  2022cites this paper
• Androgen Deficiency In Men With Chronic Obstructive Pulmonary Disease

  2022cites this paper
• Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study

  2022cites this paper
• Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review

  2022cites this paper
• Low testosterone levels as an independent risk factor for mortality in male patients with COVID-19: Report of a Single-Center Cohort Study in Mexico

  2022cites this paper
• Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.

  2022cites this paper
• Association of Male Hypogonadism With Risk of Hospitalization for COVID-19

  2022cites this paper
• Sex Differences in COVID-19 Hospitalization and Hospital Mortality among Patients with COPD in Spain: A Retrospective Cohort Study

  2022cites this paper
• Aging and sex hormones in males.

  2021cites this paper
• Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients With COVID-19

  2021cites this paper
• Effects of Environmental and Pathological Hypoxia on Male Fertility

  2021cites this paper
• The relationship of serum testosterone levels with the clinical course and prognosis of COVID‐19 disease in male patients: A prospective study

  2021cites this paper
• Sex Hormones and Lung Inflammation.

  2021cites this paper
• Correlation Between Androgen Levels and Dry Eye Parameters in Male Patients with Chronic Obstructive Pulmonary Disease

  2021influential citation
• The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic

  2021cites this paper
• Testosterone attenuates pulmonary epithelial inflammation in male rats of COPD model through preventing NRF1-derived NF-κB signaling

  2021cites this paper
• Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic

  2020cites this paper
• Pulmonary Emphysema Impairs Male Reproductive Physiology Due To Testosterone and Oxidative Stress Imbalance in Mesocricetus auratus

  2020cites this paper
• Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 (COVID-19) in SARS-CoV-2 infected male patients: a cohort study

  2020cites this paper
• Sexual Dimorphism of Coronavirus 19 Morbidity and Lethality

  2020cites this paper
• SARS-CoV-2 effects in the genitourinary system and prospects of sex hormone therapy

  2020cites this paper
• Osteoporosis in Chronic Obstructive Pulmonary Disease: More than just a Comorbidity

  2020cites this paper
• An obese 48-year-old man with progressive fatigue and decreased libido

  2019cites this paper
• Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies

  2019cites this paper
• Anaemia and iron dysregulation: untapped therapeutic targets in chronic lung disease?

  2019cites this paper
• Hypogonadism in chronic obstructive pulmonary disease (COPD): Risk factors

  2019cites this paper
• Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature

  2019cites this paper
• Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature

  2019cites this paper
• Testosterone replacement therapy and hospitalization rates in men with COPD

  2018influential citation
• Primary and Secondary Hypogonadism

  2017cites this paper
• Aging and sex hormones in males

  2017cites this paper
• Larger Testicular Volume Is Independently Associated with Favorable Indices of Lung Function

  2017cites this paper
• The impact of anaemia and iron deficiency in chronic obstructive pulmonary disease: A clinical overview.

  2017cites this paper
• Hospital admissions and mortality in patients with COPD exacerbations and vertebral body compression fractures

  2017cites this paper
• Comorbidities: Assessment and Treatment

  2017cites this paper
• Hypogonadism in Systemic Diseases

  2017cites this paper
• Aging in COPD and Idiopathic Pulmonary Fibrosis

  2016cites this paper
• Hypogonadism in patients with chronic obstructive pulmonary disease: relationship with airflow limitation, muscle weakness and systemic inflammation

  2016cites this paper
• Androgen Therapy and Rehospitalization in Older Men With Testosterone Deficiency.

  2016cites this paper
• COPD: osteoporosis and sarcopenia

  2016cites this paper
• High-resolution peripheral quantitative CT imaging: Cortical porosity, poor trabecular bone microarchitecture, and low bone strength in lung transplant recipients.

  2015cites this paper
• Underrecognized comorbidities of chronic obstructive pulmonary disease

  2015influential citation
• The Effects of Gonadotropin Replacement Therapy on Metabolic Parameters and Body Composition in Men with Idiopathic Hypogonadotropic Hypogonadism

  2015cites this paper
• Higher serum testosterone and dihydrotestosterone, but not oestradiol, are independently associated with favourable indices of lung function in community‐dwelling men

  2015cites this paper
• Fracture prevention in COPD patients; a clinical 5-step approach

  2015cites this paper
• Osteoporosis in Chronic Obstructive Pulmonary Disease

  2015cites this paper
• Association of hypogonadism with the severity of chronic obstructive pulmonary disease

  2015cites this paper
• Anaemia in chronic obstructive pulmonary disease: an insight into its prevalence and pathophysiology.

  2015cites this paper
• Musculoskeletal Disorders in Chronic Obstructive Pulmonary Disease

  2014cites this paper
• Effects of Anabolic Steroids on Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomised Controlled Trials

  2014cites this paper
• Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat

  2014cites this paper
• Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes.

  2013cites this paper
• Integration of ligand and structure-based virtual screening for identification of leading anabolic steroids.

  2013cites this paper
• Assessment of late-onset hypogonadism among male patients with chronic obstructive pulmonary disease

  2013cites this paper
• Relationship between Serum Levels of Testosterone and the Severity of Chronic Obstructive Pulmonary Disease

  2012cites this paper
• Chapter 19 – Testicular Disorders

  2011cites this paper
• World Journal of Methodology

  year unknowncites this paper
• The impact of anaemia and iron deficiency in chronic obstructive pulmonary disease: A clinical overview

  year unknowncites this paper